| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(86)92258-0 |
| P698 | PubMed publication ID | 2867345 |
| P50 | author | Ulf de Faire | Q29840595 |
| Anders Hamsten | Q30421754 | ||
| P2093 | author name string | M Björkholm | |
| G Holm | |||
| R Norberg | |||
| P2860 | cites work | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 |
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody | Q33459225 | ||
| Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | Q33478061 | ||
| The Prosser-White oration 1983. Connective tissue disease and the skin | Q33478362 | ||
| Pulmonary hypertension in systemic lupus erythematosus. | Q34995801 | ||
| Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant | Q37027827 | ||
| Hypothesis. An immunological view of atherogenesis | Q41521647 | ||
| An immunological approach to ageing | Q43809286 | ||
| AUTOIMMUNE MECHANISMS IN HUMAN VASCULAR DISEASE | Q57249967 | ||
| Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE | Q69941578 | ||
| Veno-occlusive disease in systemic lupus erythematosus: possible association with anticardiolipin antibodies? | Q70612539 | ||
| Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis | Q71505016 | ||
| Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis | Q71599044 | ||
| P433 | issue | 8473 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 113-116 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events | |
| P478 | volume | 1 |
| Q28195850 | 21-year-old patient with myocardial infarct, transient cerebral ischemia and thrombocytopenia |
| Q94453403 | A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome |
| Q60678824 | Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies |
| Q41265519 | Acute myocardial infarction in patients of nephrotic syndrome: a case series |
| Q35444451 | Acute myocardial infarction in young adults with antiphospholipid syndrome: report of two cases and literature review |
| Q34498392 | Acute myocardial infarction in young adults: causes and management |
| Q33492695 | An acquired-pseudo Bernard Soulier syndrome occurring with autoimmune chronic active hepatitis and anti-cardiolipin antibody |
| Q44234343 | Annexin V levels in survivors of early myocardial infarction |
| Q46941158 | Anti-cardiolipin antibodies in ischaemic heart disease. |
| Q38885685 | Anti-phospholipid Antibodies and Smoking: An Overview |
| Q41673431 | Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease |
| Q71691168 | Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study |
| Q55365972 | Anticardiolipin antibodies and cardiovascular disease. |
| Q50895197 | Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. |
| Q68026186 | Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus |
| Q78081213 | Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study |
| Q44087908 | Anticardiolipin antibodies are no marker for survived myocardial infarction |
| Q72402253 | Anticardiolipin antibodies in an unselected stroke population |
| Q47988430 | Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events |
| Q33612761 | Anticardiolipin antibodies in ischaemic heart disease: marker or myth? |
| Q69425847 | Anticardiolipin antibodies in patients with rheumatoid arthritis |
| Q79245648 | Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis |
| Q53354829 | Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. |
| Q36707524 | Anticardiolipin antibodies--clinical associations |
| Q36723030 | Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease |
| Q72858717 | Antilipoprotein antibodies in rheumatoid arthritis |
| Q33384580 | Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis |
| Q35356556 | Antiphospholipid antibodies and cardiovascular disease |
| Q73086663 | Antiphospholipid antibodies and the antiphospholipid antibody syndrome |
| Q37358421 | Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein |
| Q71482152 | Antiphospholipid antibodies in heart transplant recipients |
| Q41682862 | Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss |
| Q33328463 | Antiphospholipid antibody syndrome |
| Q55462735 | Antiphospholipid antibody syndrome: a review. |
| Q34331685 | Antiphospholipid syndrome; its implication in cardiovascular diseases: a review |
| Q73103175 | Antiphospholipid thrombosis syndromes |
| Q33814868 | Antiphospholipids in cutaneous vasculitis |
| Q74537091 | Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome |
| Q41940433 | Arterial thrombotic manifestations in young women associated with the lupus anticoagulant |
| Q73251576 | Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease |
| Q64262888 | Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form |
| Q44532737 | Case report: Acute myocardial infarction in a 32-year-old white male found to have antiphospholipid antibody syndrome and MTHFR mutation homozygosity |
| Q33562091 | Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus |
| Q61914430 | Chapter 8 Systemic Manifestations of the Antiphospholipid Syndrome |
| Q33729825 | Clinical Characteristics of Patients Less than Forty Years Old with Coronary Artery Disease in Taiwan: A Cross-Sectional Study |
| Q40519206 | Clinicopathologic correlations of the antiphospholipid syndrome |
| Q69890603 | Coronary artery bypass graft failure--an autoimmune phenomenon? |
| Q37140146 | Coronary artery fistula presenting as unstable angina pectoris in patients with antiphospholipid syndrome |
| Q33494721 | Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study |
| Q37853050 | Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome |
| Q33655220 | Diagnosis and management of inherited and acquired thrombophilias |
| Q68116739 | Echocardiographic diagnosis of bland thrombus on an aortic valve |
| Q77375392 | Echocardiographic evaluation of patients with primary antiphospholipid syndrome |
| Q44202937 | Elevated levels of Factor XI are associated with cardiovascular disease in women |
| Q69395955 | Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986 |
| Q28319260 | Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus |
| Q68134484 | High aortic occlusion associated with lupus anti-coagulant |
| Q35818114 | High frequency of spontaneous acute myocardial infarction due to small coronary artery disease in dead (NZWxBXSB)F1 male mice |
| Q74456594 | Hughes (antiphospholipid) syndrome. Clinical features |
| Q42773864 | Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response |
| Q38146984 | Humoral autoimmunity in systemic rheumatic disease. A review. |
| Q71477718 | IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis |
| Q33379907 | Immunology and Clinical Importance of Antiphospholipid Antibodies |
| Q33492572 | Importance of serum anticardiolipin antibody levels in coronary heart disease |
| Q78043773 | Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients |
| Q68416136 | Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin |
| Q33564078 | Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis. |
| Q73342706 | Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty |
| Q70892892 | Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis |
| Q34538210 | Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study |
| Q70376785 | Management of retinal vein occlusion |
| Q42741694 | Myocardial infarction in children: Two interesting cases |
| Q33809269 | Myocardial infarction in young adults-risk factors and pattern of coronary artery involvement |
| Q42947383 | National STD trends in Zambia: 1987-89 |
| Q50101627 | New-onset Takayasu's Arteritis as Acute Myocardial Infarction |
| Q33498327 | Pathogenesis and treatment of the antiphospholipid antibody syndrome |
| Q72159919 | Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass |
| Q40582616 | Platelet factors predisposing to arterial thrombosis |
| Q51006300 | Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study. |
| Q87342421 | Prevalence and pathology of vascular occlusive disease in the antiphospholipid syndromes |
| Q67786064 | Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis |
| Q34674429 | Primary anti-phospholipid antibody syndrome (APS): current concepts |
| Q43446662 | Primary antiphospholipid syndrome (PAPS). Two case reports and therapeutic implications |
| Q71764988 | Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies |
| Q48226068 | Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction |
| Q73778589 | Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery |
| Q73835437 | Relation between left ventricular and/or left atrial thrombus and anticardiolipin antibodies in patients with acute myocardial infarction |
| Q33562467 | Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome |
| Q35549777 | Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome |
| Q34173872 | Risk factors for development of left ventricular thrombus after first acute anterior myocardial infarction-association with anticardiolipin antibodies |
| Q33494866 | Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome |
| Q69893326 | Standardising the anti-cardiolipin antibody test |
| Q33393937 | The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. |
| Q40544880 | The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates. |
| Q36434130 | The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis |
| Q35966558 | The role of antiphospholipid antibodies in stroke. |
| Q69676670 | The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus |
| Q53643980 | Thrombophilic state in young patients with acute myocardial infarction. |
| Q77492467 | Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies? |
| Q35702083 | Vascular disease, thrombosis, and recurrent abortion |
| Q68917663 | [Antiprothrombinase and myocardial infarction. Apropos of 2 cases] |
| Q74299032 | [Intracardial thrombosis and primary antiphospholipid syndrome. A familial case report] |
| Q73960298 | [Prevalence of antiphospholipid syndrome in patients under 65 years of age with acute myocardial infarction] |
Search more.